Is There A Path To End
The Autism Epidemic?
New published science and the screening of at-risk children before they receive any vaccines may provide a middle ground between the “all or nothing” positions of the two warring sides of the vaccine-autism debate, according to one of the leading critics of the government’s current vaccination program.
On one side of the debate are parents who believe that today’s high number of mandatory vaccinations (children in the 1960s received three vaccinations, today’s children receive 38) can cause autism in vulnerable children. On the other side are government health officials who deny any a link.
However, critics claim the government is being influenced by pharmaceutical companies whose revenues from vaccines exploded from $170 million in the early 1980s to more than $60 billion today. A study published in 2013 in the European Journal of Clinical Investigation concluded that the pharmaceutical industry “masterfully influences evidence base production” and also “exerts direct influences on professional decisions and health consumers.”
“There is a wealth of relevant scientific studies that prove that autism prevalence has skyrocketed in the United States,” says J.B. Handley, the father of a child with autism and author of the bookHow To End The Autism Epidemic (https://www.chelseagreen.com/product/how-to-end-the-autism-epidemic/.)
“And since 2004 there have been 11 groundbreaking discoveries in separate but related scientific fields that, taken together, reveal one of the causes of autism.”
Handley says those discoveries, published in peer-reviewed journals, include the work of such respected researchers as Dr. Carlos Pardo-Villamizar, a neurologist at Johns Hopkins; Dr. Christopher Exley, a professor of bioinorganic chemistry at Keele University in England, and the late Dr. Paul Patterson, a professor of biological sciences at the California Institute of Technology.
“Because of this new, published science,” Handley says, “we now know that autism is created by immune activation events in the brain during critical phases of brain development, typically by the time a child is 36-months-old, and that these immune activation events in the brain can be triggered by the aluminum adjuvant in vaccines. While the first of these discoveries occurred in 2004, the critical missing pieces have only fallen into place since 2010.”
All the while, the autism rate has exploded. The Center for Disease Control and Prevention noted that the rates for autism in children went from 1 in 150 children in 2000 to 1 in 36 children in 2017.
Handley says returning to the vaccine schedule used in the mid-1980s provides a moderate solution. He also believes that there should be thorough screening before any vaccines are given to determine which children are at-risk from serious vaccine injury.
“We have the capacity to systematically assess the children who are more vulnerable before they receive a vaccine,” Handley says. “These children are at risk and it is the duty of our public health program to protect them.”
Handley believes these are some of the steps that should be taken:
About J.B. Handley
J.B. Handley is the co-founder and chairman of Generation Rescue, a non-profit organization focused on helping children recover from autism that was inspired by the journey of his son, Jamison, who was diagnosed with autism in 2004. Author of the book How To End the Autism Epidemic(https://www.chelseagreen.com/product/how-to-end-the-autism-epidemic/), he is also the co-producer of the documentary film Autism Yesterday and the co-founder of the Age of Autism blog. Handley co-founded Swander Pace Capital, a middle-market private equity firm with more than $1.5 billion under management where he served as managing director for two decades. He is an honors graduate of Stanford University and lives in Portland, Oregon, with his wife, Lisa, and their three children.